1) Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O'Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S;AVERROES Steering Committee and Investigators:Apixaban in patients with atrial fibrillation. N Engl J Med 364:806-817, 2011
2) Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L;ARISTOTLE Committees and Investigators:Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981-992, 2011
3) Hankey GJ, Stevens SR, Piccini JP, Lokhnygina Y, Mahaffey KW, Halperin JL, Patel MR, Breithardt G, Singer DE, Becker RC, Berkowitz SD, Paolini JF, Nessel CC, Hacke W, Fox KA, Califf RM;ROCKET AF Steering Committee and Investigators:Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban:the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke 45:1304-1312, 2014
4) Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S:Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran:the RE-LY trial. Stroke 43:1511-1517, 2012
5) Hess A, Klein I, Iung B, Lavallée P, Ilic-Habensus E, Dornic Q, Arnoult F, Mimoun L, Wolff M, Duval X, Laissy JP:Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR Am J Neuroradiol 34:1579-1584, 2013
6) Katoh M, Yoshino M, Asaoka K, Aoki T, Imamura H, Kashiwazaki D, Takano K, Aida T:A restricted subarachnoid hemorrhage in the cortical sulcus in cerebral amyloid angiopathy:could it be a warning sign? Surg Neurol 68:457-460, 2007
7) Khurram A, Kleinig T, Leyden J:Clinical associations and causes of convexity subarachnoid hemorrhage. Stroke 45:1151-1153, 2014
8) Kumar S, Goddeau RP Jr, Selim MH, Thomas A, Schlaug G, Alhazzani A, Searls DE, Caplan LR:Atraumatic convexal subarachnoid hemorrhage:clinical presentation, imaging patterns, and etiologies. Neurology 74:893-899, 2010
9) Lip GY, Larsen TB, Skjøth F, Rasmussen LH:Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. J Am Coll Cardiol 60:738-746, 2012
10) Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY:A novel user-friendly score(HAS-BLED)to assess 1-year risk of major bleeding in patients with atrial fibrillation:the Euro Heart Survey. Chest 138:1093-1100, 2010
11) Takeda S, Yamazaki K, Miyakawa T, Onda K, Hinokuma K, Ikuta F, Arai H:Subcortical hematoma caused by cerebral amyloid angiopathy:does the first evidence of hemorrhage occur in the subarachnoid space? Neuropathology 23:254-261, 2003